alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### Floods of June 1965 in Arkansas River basin, Colorado, Kansas, and New Mexico

By: R.J. Snipes

                            https://doi.org/10.3133/wsp1850D

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plates:                               - **Plate 1**                            (pdf)
  - **Plate 2**                            (pdf) 
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

Defense Logistics AgencyThe Nation's Combat Logistics Support Agency

Search
Search

Search

-  Home		 
-  What DLA Offers    -  Excess Property Disposal             
  -  Document Services             
  -  Products             
  -  Services             
  -  Programs 
-  Working With DLA    -  Applications             
  -  Small Business             
  -  Federal and International Cataloging             
  -  Defense Data Standards             
  -  Events             
  -  Procurement Policies             
  -  Government Programs             
  -  Forms 
-  Organizations    -  DLA Headquarters             
  -  DLA Aviation             
  -  DLA Disposition Services             
  -  DLA Distribution             
  -  DLA Energy             
  -  DLA Land and Maritime             
  -  DLA Troop Support             
  -  DLA CENTCOM & SOCOM             
  -  DLA Europe & Africa             
  -  DLA Indo-Pacific 
-  Customer Support    -  Self Help Tools             
  -  How to Order             
  -  Find Your Order             
  -  Customer Facing Offices             
  -  Training             
  -  Brochures             
  -  Warfighter Support             
  -  Customer Service Management 
-  Careers		 
-  About DLA    -  Contact Us             
  -  Locations             
  -  Leaders             
  -  News             
  -  History             
  -  Media Gallery             
  -  DLA Campaigns 

HomeAbout DLANewsNews Article View

PHOTO INFORMATION

** Download

** Details

** Share

PHOTO INFORMATION

** Download

** Details

** Share

PHOTO INFORMATION

** Download

** Details

** Share

# 21st Theater Support Command Senior Enlisted Advisor visits DLA Distribution Susquehanna, Pennsylvania

By Diana DawaDLA Distribution Public Affairs

                NEW CUMBERLAND, Pa.  –              21st Theater Sustainment Command’s Senior Enlisted Advisor, Command Sgt. Maj. Rocky Carr, visited DLA Distribution Susquehanna Pennsylvania, Oct. 11.  The purpose of his visit was to receive an orientation of DLA Distribution’s mission and function, tour the Eastern Distribution Center, receive operations briefings, and visit with personnel. 

**                    SHARE                

**                    PRINT                

DLADLA DistributionDistribution21st Theater Sustainment CommandDLA Distribution Susquehanna PennsylvaniaEastern Distribution Center
Exhibit 31.1

            PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

I, Donald R. Mayer, certify that:

1.    I have reviewed this quarterly report on Form 10-QSB of WorldNet, Inc.
of Nevada;

2.    Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statement made, in light of the circumstances under which statements
were made, not misleading with respect to the period covered by this quarterly
report;

3.    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this report.

4.    The small business issuer's other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
small business issuer and have:

      (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;

      (b) Evaluated the effectiveness of the small business issuer's
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation;
and

      (c) Disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the small business
issuer's internal control over financial reporting; and

5.    The small business issuer's other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the small business issuer's auditors and the audit
committee of small business issuer's board of directors (or persons performing
the equivalent function):

      (a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

      (b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the small business issuer's
internal control over financial reporting.

                               /s/ Donald R. Mayer
Date: August 8, 2006          ____________________________________________
                              Donald R. Mayer, Principal Executive Officer
**EXHIBIT 32.2**

CERTIFICATIONPURSUANT TO 18 U.S.C. sec. 1350,AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Inconnection with the Quarterly Report of IWT Tesoro Corporation (the “Company”)on Form 10-Q for the quarter ended June 30, 2006, as filed with the Securitiesand Exchange Commission on the date hereof (the “Report”), I, Forrest P.Jordan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, that:

(1)           The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of1934; and

(2)           The information contained in theReport fairly presents, in all material respects, the financial condition and resultof operations of the Company.

Theforegoing certification shall not be deemed to be filed for the purposes ofSection 18 of the Securities and Exchange Act of 1934 or otherwise subject toliability under this section. This certification shall not be deemed to beincorporated by reference into any filing under the Securities Act of 1933 orthe Exchange Act except to the extent that this Exhibit 32.2 is expresslyincorporated by reference in any such filing.

 
| Dated: August 11, 2006 | /s/Forrest P.  Jordan    |   |
|------------------------|--------------------------|--------|
|                   | Forrest P.  Jordan       |
|                   | Chief Financial  Officer |

 

A signed original of this written statement requiredby 18 U.S.C. Section 1350 has been provided to the Company and will be retainedby the Company and furnished to the Securities and Exchange Commission or itsstaff upon request.

 

----
# C_2014431EN.01002001.xml

| 1.12.2014 | EN | Official Journal of the European Union | C 431/20 |
| --- | --- | --- | --- |

1.12.2014

EN

Official Journal of the European Union

C 431/20

---

Order of the General Court of 17 September 2014 — Afepadi and Others v Commission

(Case T-354/12) (1)

1

((Action for annulment - Health claims made in the labelling and advertising of foods - Regulation (EU) No 432/2012 - Recitals 11, 14 and 17 - Act not amenable to review - Inadmissibility))

(2014/C 431/34)

Language of the case: Spanish

Parties

Parties

Applicants: Asociación Española de Fabricantes de Preparados alimenticios especiales, dietéticos y plantas medicinales (Afepadi) (Barcelona, Spain); Elaborados Dietéticos, SA (Palma de Cervelló, Spain); Nova Diet, SA (Burgos, Spain); Laboratorios Vendrell, SA (Barcelona); and Ynsadiet, SA (Leganés, Spain) (represented by: P. Velázquez González, lawyer)

Applicants:

Defendant: European Commission (represented by: S. Grünheid and P. Němečková, acting as Agents)

Defendant:

Intervener in support of the defendant: French Republic (represented by: D. Colas and S. Menez, acting as Agents)

Intervener in support of the defendant:

Re:

Re:

In particular, an action for the annulment of recitals 11, 14 and 17 of Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (OJ 2012 L 136, p. 1).

Operative part of the order

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | Asociación Española de Fabricantes de Preparados alimenticios especiales, dietéticos y plantas medicinales (Afepadi), Elaborados Dietéticos, SA, Nova Diet, SA, Laboratorios Vendrell, SA and Ynsadiet, SA shall bear their own costs and pay those incurred by the European Commission. |
| --- | --- |

2.

Asociación Española de Fabricantes de Preparados alimenticios especiales, dietéticos y plantas medicinales (Afepadi), Elaborados Dietéticos, SA, Nova Diet, SA, Laboratorios Vendrell, SA and Ynsadiet, SA shall bear their own costs and pay those incurred by the European Commission.

---

(1)  OJ C 295, 29.9.2012.

1

---
# C_2012209EN.01001002.xml

| 14.7.2012 | EN | Official Journal of the European Union | C 209/10 |
| --- | --- | --- | --- |

14.7.2012

EN

Official Journal of the European Union

C 209/10

---

Action brought on 16 May 2012 — GRE v OHIM — Villiger Söhne (LIBERTE american blend)

(Case T-205/12)

2012/C 209/17

Language in which the application was lodged: German

Parties

Parties

Applicant: GRE Grand River Enterprises Deutschland GmbH (Kloster Lehnin, Germany) (represented by: I. Memmler and S. Schulz, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Villiger Söhne GmbH (Waldshut-Tiengen, Germany)

Other party to the proceedings before the Board of Appeal:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 1 March 2012 in Case R 387/2011-1; |
| --- | --- |

—

annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 1 March 2012 in Case R 387/2011-1;

| — | order the defendant to pay the costs. |
| --- | --- |

—

order the defendant to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: the applicant

Applicant for a Community trade mark:

Community trade mark concerned: the figurative mark ‘LIBERTE american blend’ for goods in Class 34 — application No 7 481 211

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: Villiger Söhne GmbH

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: the word mark ‘LA LIBERTAD’ and the figurative mark ‘La LIBERTAD’ for goods in Classes 14 and 34

Mark or sign cited in opposition:

Decision of the Opposition Division: the opposition was upheld

Decision of the Opposition Division:

Decision of the Board of Appeal: the appeal was dismissed

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8(1)(b) of Regulation No 207/2009

Pleas in law:

---
Before the First Division,

March 17, 1942

No. 47007.

#### Petition 6277-R of L. Strauss & Co., Inc. (Indianapolis).

Opinion by

Oliver, P. J.

The petition having been formally abandoned was dismissed without prejudice.
**ARMANDO
                  C. IBARRA**
                **Certified
                  Public Accountants**
                **A
                  Professional Corporation**
  ****
 Members
        of the California Society of Certified Public Accountants
 
 
 
 June
        14,
        2006
 
 
 To
        Whom It May Concern:
 
 The
        firm
        of Armando C. Ibarra, Certified Public Accountants, APC consents to the
        inclusion of our report of August 16, 2005, on the audited consolidated
        financial statements of Seychelle Environmental Technologies, Inc., as of
        February 28, 2005 and February 29, 2004, in any filings that are necessary
        now
        or in the near future with the U.S. Securities and Exchange Commission.
 
 
 
 Very
        truly yours,
 
 /s/
        Armando C.Iberra _________
 ARMANDO
        C. IBARRA, C.P.A.
Edward Thomas Zakarian, Private Pilot – Section 333 Amendment Petition

To: U.S. Department of Transportation, Docket Operations

West Building Ground Floor, Rm. W12-140

1200 New Jersey Ave, SE

Washington, DC 20590

Fr: Edward Thomas Zakarian, 3169 Santa Margarita Road, West palm Beach, Florida 

33411

Date: December 27, 2015

Regarding: Request to amend and allow for an additional aircraft on 

exemption #11739 and #11739A, docket No. FAA-2015-0893 and to amend 

altitude to include “at or below 400 feet Above Ground Level” (AGL).

Dear Sir or Madam:

On June 5, 2015, I was granted exemption under Section 333 of the “FAA Modernization 

and Reform Act of 2012” (the “Reform Act”), number 11739 for the purpose of aerial 

data collection. I respectfully request to amend my exemption to allow for an additional 

sUAS, the DJI Inspire 1 (Pro), to be operated in full compliance with the conditions as set 

forth within subject exemption.

Exemption No. 11739 allowed for operation of the DJI Phantom 2 Vision + UAS. On 

November 5, 2015, I was granted Amendment No. 11739A, for the addition of the DJI 

Phantom 3. As technology progresses and improves with each new generation of quad 

copter, clients seek service providers offering the latest imagery. Consequently, I am 

requesting to add the new DJI Inspire 1 to my COA. The DJI Inspire 1 continues to 

operate with the same or greater level of safety standards and possesses the same 

operating specifications and similar weight criteria as can be found in the operating 

manual attached, but with the addition of technology upgrades to its electronics making 

this an even safer aircraft to operate. The DJI Inspire 1 will be operated in full 

compliance within the same terms and conditions contained under Exemption 11739 and 

11739A and within the safety guidelines specified in the manufacturers operating manual. 

I have attached DJI Inspire 1 manual in the docket for your reference.

I also request subject exemption be amended from the current “at or below 200 feet 

AGL” limitation to “at or below 400 feet AGL”. This altitude limitation has been granted 

in similar exemptions such as Exemption No. 12157. Authorization to operate at or 

below 400 feet AGL shall be conducted in accordance to all FAA airspace and safety 

guidelines and would allow my services to be competitive to other Aerial Data Collection 

companies permitted to operate at the higher altitude.

As there is no change in the conditions of Exemption 11739 or 11739A, other than those 

specified above, the exemption awarded continues to benefit the public interest and 

safety, I request my petition to amend subject exemption be granted. Further, should the 
Edward Thomas Zakarian, Private Pilot – Section 333 Amendment Petition

examiner determine not to approve either of my two proposed amendments, I ask they be 

considered individually so as not to negatively effect one another.

Sincerely,

Edward Thomas Zakarian
##### 



1.
    
    I have reviewed this quarterly report on Form 10-QSB of O2Diesel Corporation;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this quarterly report;3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;4.
    
    The registrants other certifying officer and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:
     5.
    
    The registrants other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of registrants board of directors (or
persons performing the equivalent functions):
   Date: August 15, 2005
    
    By:
    
    /s/ Alan RaeName:
    
    Alan RaeTitle:
    
    Chief Executive Officer and Acting Financial Officer(Principal Executive and Financial Officer)
 12
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection with the Quarterly Report of Shoreside Investments, Inc. (the
"Company")  on Form 10-QSB for the period ended September 30, 2002 as filed with
the  Securities  and  Exchange  Commission on the date hereof (the "Report"), I,
Robert  M. Karz, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C.  section  1350,  as adopted pursuant to section 906 of the Sarbanes-Oxley
Act  of  2002,  that  to  the  best  of  my  knowledge:

     (1)  The  Report  fully  complies with the requirements of section 13(a) or
15(d)  of  the  Securities  Exchange  Act  of  1934;  and

     (2)  The  information  contained  in  the  Report  fairly  presents, in all
material  respects,  the  financial  condition  and  result of operations of the
Company.




                         /s/ Robert  M.  Karz
                         ------------------------
                         Chief  Executive  Officer
                         November  13,  2002
# C_2015363EN.01002602.xml

| 3.11.2015 | EN | Official Journal of the European Union | C 363/26 |
| --- | --- | --- | --- |

3.11.2015

EN

Official Journal of the European Union

C 363/26

---

Judgment of the General Court of 15 September 2015 — Novartis Europharm v Commission

(Case T-472/12) (1)

1

((Medicinal products for human use - Marketing authorisation for the generic medicinal product Zoledronic acid Teva Pharma - zoledronic acid - Regulatory data protection period for the reference medicinal products Zometa and Aclasta, containing the active substance zoledronic acid - Directive 2001/83/EC - Regulation (EEC) No 2309/93 and Regulation (EC) No 726/2004 - Global marketing authorisation - Regulatory data protection period))

(2015/C 363/34)

Language of the case: English

Parties

Parties

Applicant: Novartis Europharm Ltd (Horsham, United Kingdom) (represented by: C. Schoonderbeek, lawyer)

Applicant:

Defendant: European Commission (represented: initially by A. Sipos, and, subsequently by M. Wilderspin, P. Mihaylova and M. Šimerdová, acting as Agents)

Defendant:

Intervener in support of the defendant: Teva Pharma BV (Utrecht, Netherlands) (represented by: K. Bacon, Barrister, and C. Firth, Solicitor)

Intervener in support of the defendant:

Re:

Re:

Application for annulment of Commission Implementing Decision C (2012) 5894 final of 16 August 2012 granting a marketing authorisation in accordance with Regulation (EC) No 726/2004 of the European Parliament and of the Council for the medicinal product for human use ‘Zoledronic acid Teva Pharma — zoledronic acid’.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Novartis Europharm Ltd to bear its own costs and to pay the costs incurred by the European Commission and by Teva Pharma BV. |
| --- | --- |

2.

Orders Novartis Europharm Ltd to bear its own costs and to pay the costs incurred by the European Commission and by Teva Pharma BV.

---

(1)  OJ C 389, 15.12.2012.

1

---